Physician profile
Gerald E Gronborg
NPI 1902884950
$1,319.62
in general payments reported to CMS, 2019-2025
17 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.67 · 2020: $122 · 2021: $137 · 2022: $109 · 2023: $235 · 2024: $210 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $720.20 | 2020-2025 | Affinity, Puraply, Affinity |
| Smith+Nephew, INC. | $222.56 | 2023-2025 | Stravix, Grafix Pl |
| Convatec INC. | $121.57 | 2025 | |
| Abbvie INC. | $32.33 | 2025 | |
| Averitas Pharma INC. | $22.06 | 2025 | Qutenza |
| Upsher-Smith Laboratories LLC | $21.62 | 2019 | |
| Inspire Medical Systems, INC. | $21.41 | 2025 | Inspire |
| Sunovion Pharmaceuticals INC. | $18.24 | 2020 | |
| Solventum Corporation | $18.23 | 2024 | Activ.A.C. |
| Tanabe Pharma America, INC. | $17.98 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.47 | 2023 | Trintellix |
| Lilly USA, LLC | $15.56 | 2025 | Zepbound |
| Axsome Therapeutics, INC. | $15.55 | 2025 | Symbravo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.36 | 2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $14.07 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $13.36 | 2020 | |
| Depuy Synthes Sales INC. | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Gronborg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.